Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Impact of Consolidative Cellular Therapy with DLI or Second Transplant in Patients with AML Who Achieve Complete Remission Following Post-Transplant Relapse

H. Moses Murdock, Haesook T. Kim, Katie Maurer, Amar H. Kelkar, Roman M. Shapiro, Mahasweta Gooptu, Rizwan Romee, Corey S. Cutler, John Koreth, Jerome Ritz, Joseph H. Antin, Vincent T. Ho, Sarah Nikiforow, Catherine J. Wu, Robert J. Soiffer

Blood (2024) 144 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2024-204343

Published: 2024

Journal Articles

Feasibility, Safety and Efficacy of Oral Maintenance Therapy with Venetoclax Plus Decitabine/Cedazuridine after Venetoclax Plus FluBu2 for High Risk MDS/AML Undergoing RIC Allo-HCT

Jacqueline S. Garcia, Haesook T. Kim, Jennifer Brock, H. Moses Murdock, Mahasweta Gooptu, Vincent T. Ho, Roman M. Shapiro, Christopher J. Gibson, Amar H. Kelkar, Corey S. Cutler, Denbaa Bat-Erdene, Jeremy Ryan, Anna Bosch-Vilaseca, Anthony G. Letai, Jerome Ritz, Coleman Lindsley, Robert J. Soiffer, Joseph Antin

Blood (2024) 144 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2024-194170

Published: 2024

Journal Articles

Racial Disparities in Major Adverse Cardiovascular and Cerebrovascular Events Among Hospitalized Patients with Leukemia: A National Analysis

Kanishka Uttam Chandani, Siddharth pravin Agrawal, Maharshi Raval, Sajid Siddiq, Ahmed Nadeem, Amar H. Kelkar

Blood (2024) 144 (Supplement 1): 7796.

https://doi.org/10.1182/blood-2024-212308

Published: 2024

Journal Articles

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

Rubí Alejandra A Orta-Martínez, Fernando J Medina-Olivares, Gregory Abel, Anna Revette, Amar H. Kelkar, Erica O Koranteng, Maria del Campo-Martinez, Efreen Montano Figueroa, Brenda Lizeth Acosta Maldonado, Efrain Aquino-Fernandez, Luis Mario Villela Martinez, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 5205.

https://doi.org/10.1182/blood-2024-208223

Published: 2024

Journal Articles

Induction of Graft-Versus-Leukemia Effect with Treg-Depleted DLI Plus Ipilimumab for Myeloid Disease Relapse after HLA-Matched Transplant

Roman M. Shapiro, Haesook T. Kim, William H Terral, Vincent T. Ho, Mahasweta Gooptu, Rizwan Romee, Christopher J. Gibson, Amar H. Kelkar, Corey S. Cutler, Joseph H. Antin, Katie Maurer, Catherine J. Wu, Robert Zeiser, Jerome Ritz, Robert J. Soiffer, Sarah Nikiforow, John Koreth

Blood (2024) 144 (Supplement 1): 4833.

https://doi.org/10.1182/blood-2024-194102

Published: 2024

Journal Articles

Using Circulating Tumor DNA to Spare Patients with DLBCL Unnecessary Treatment and Cost: A Model-Based Analysis

Edward R Scheffer Cliff, David A Russler-Germain, Amar H. Kelkar

Blood (2024) 144 (Supplement 1): 3657.

https://doi.org/10.1182/blood-2024-207430

Published: 2024

Journal Articles

Ulcerative Colitis and Adverse Outcomes in Hematopoietic Stem Cell Transplantation: A Nationwide Analysis

Kanishka Uttam Chandani, Siddharth pravin Agrawal, Maharshi Raval, Dev Lotia, Ahmed Nadeem, Amar H. Kelkar

Blood (2024) 144 (Supplement 1): 4951.

https://doi.org/10.1182/blood-2024-212343

Published: 2024

Journal Articles

Redefining Clinical Response Criteria in Myelodysplastic Syndromes to Better Forecast Post-Transplant Outcomes

Blood (2024) 144 (Supplement 1): 4938.

https://doi.org/10.1182/blood-2024-209087

Published: 2024

Journal Articles

Effective Prevention of Steroid-Requiring Chronic Graft-Vs.-Host Disease with B Cell Depletion: A Randomized, Placebo-Controlled Trial

Blood (2023) 142 (Supplement 1): 649.

https://doi.org/10.1182/blood-2023-180142

Published: 2023

Journal Articles

Impact of Clinical and Genetic Factors on Myelofibrosis Outcomes after Allogeneic Transplantation

Mahasweta Gooptu, Haesook T. Kim, Kaina Chen, Ann Mullally, Joseph Antin, Corey Cutler, Amar H Kelkar, John Koreth, Roman M. Shapiro, Robert J. Soiffer, Daniel J. DeAngelo, Jacqueline S. Garcia, Marlise R. Luskin, Richard M Stone, Martha Wadleigh, Eric S. Winer, R. Coleman Lindsley, Vincent Ho

Blood (2023) 142 (Supplement 1): 4978.

https://doi.org/10.1182/blood-2023-178684

Published: 2023

Journal Articles

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Blood (2023) 142 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2023-185315

Published: 2023

Journal Articles

Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

Blood (2023) 142 (Supplement 1): 3618.

https://doi.org/10.1182/blood-2023-185220

Published: 2023

Journal Articles

Feasibility of Utilizing a Virtual Health Assistant during Inpatient Reduced-Intensity Allogeneic Transplantation

Amar H Kelkar, Chantal Kerssens, Nicholas Groblewski, Dillon D Clancy, Hajime Uno, Corey Cutler, Danielle Sherman-Manhard, Robert J. Soiffer, Victor HS Wang, Gregory A Abel

Blood (2023) 142 (Supplement 1): 5104.

https://doi.org/10.1182/blood-2023-178619

Published: 2023

Journal Articles

Analysis of Repeated Roles in Editorial Boards at Oncology-Focused Journals

Lama Sawalha, Ghulam Rehman Mohyuddin, Aaron M. Goodman, Nico Gagelmann, Amar H. Kelkar, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 5092–5093.

https://doi.org/10.1182/blood-2022-157443

Published: 2022

Journal Articles

Anticoagulant Usage Patterns for Acute Venous Thromboembolism in Patients with Advanced Liver Disease

Amar H Kelkar, MD, Mona A Kelkar, MBA, Anita Rajasekhar, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142786

Published: 2020

NARROW

Impact of Consolidative Cellular Therapy with DLI or Second Transplant in Patients with AML Who Achieve Complete Remission Following Post-Transplant Relapse

Feasibility, Safety and Efficacy of Oral Maintenance Therapy with Venetoclax Plus Decitabine/Cedazuridine after Venetoclax Plus FluBu2 for High Risk MDS/AML Undergoing RIC Allo-HCT

Racial Disparities in Major Adverse Cardiovascular and Cerebrovascular Events Among Hospitalized Patients with Leukemia: A National Analysis

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

Induction of Graft-Versus-Leukemia Effect with Treg-Depleted DLI Plus Ipilimumab for Myeloid Disease Relapse after HLA-Matched Transplant

Using Circulating Tumor DNA to Spare Patients with DLBCL Unnecessary Treatment and Cost: A Model-Based Analysis

Ulcerative Colitis and Adverse Outcomes in Hematopoietic Stem Cell Transplantation: A Nationwide Analysis

Redefining Clinical Response Criteria in Myelodysplastic Syndromes to Better Forecast Post-Transplant Outcomes

Effective Prevention of Steroid-Requiring Chronic Graft-Vs.-Host Disease with B Cell Depletion: A Randomized, Placebo-Controlled Trial

Impact of Clinical and Genetic Factors on Myelofibrosis Outcomes after Allogeneic Transplantation

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

Feasibility of Utilizing a Virtual Health Assistant during Inpatient Reduced-Intensity Allogeneic Transplantation

Analysis of Repeated Roles in Editorial Boards at Oncology-Focused Journals

Anticoagulant Usage Patterns for Acute Venous Thromboembolism in Patients with Advanced Liver Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only